Chemoprotective effects of Ulva lactuca (green seaweed) aqueous-ethanolic extract against subchronic exposure to benzo(a)pyrene by CYP1A1 inhibition in mice.


Journal

Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 25 05 2018
revised: 02 12 2018
accepted: 21 12 2018
pubmed: 8 2 2019
medline: 14 6 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

The protective effect of the supplementation with an aqueous-ethanolic extract obtained from Ulva lactuca (Delile) green seaweed on benzo[a] pyrene-induced damage in mice was evaluated. Animals were treated with oral doses of U. lactuca extract (100 and 400 mg/kg) for 9 weeks. They were exposed to 50 mg/kg of oral doses of benzo(a)pyrene starting from the second week and up to the fifth week. Groups treated with benzo(a)pyrene only (second to fifth weeks), sunflower oil (vehicle, 9 weeks), or U. lactuca extract (100 and 400 mg/kg, 9 weeks) were also included in the study. The treatment with 400 mg/kg of the extract ameliorated the oxidative damage, decreased IL-1β and TNF-α levels, and favorably regulated the antioxidant defenses compared with benzo(a)pyrene-exposed group. The benzo(a)pyrene-induced DNA damage was also reduced, as it was evidenced by the lower micronucleus formation in U. lactuca extract-supplemented animals. The extract protected the hepatic tissue, and it reduced the liver activity/expression of CYP1A1. These results altogether suggested a chemoprotective effect of U. lactuca extract against benzo(a)pyrene-induced-toxicity in mice, probably associated with an inhibitory effect of carcinogen bioactivation.

Identifiants

pubmed: 30729585
doi: 10.1002/ptr.6289
doi:

Substances chimiques

Benzo(a)pyrene 3417WMA06D
Cytochrome P-450 CYP1A1 EC 1.14.14.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

958-967

Subventions

Organisme : Visiting Research Program
ID : 400768/2014-3
Organisme : National Program of Biodiversity, Agency of Environment (AMA, CITMA)

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Livan Delgado-Roche (L)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.
Center A.F. for Technology Studies (CAFET), Carnot Laboratory, México City, Mexico.

Idania Rodeiro (I)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.

Mario Riera (M)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.

José Alfredo Herrera (JA)

Institute of Materials Science and Technology (IMRE), Havana University, Havana, Cuba.

Ivonilce Venturi (I)

Programa de Pós-graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí, Brazil.

Yasnay Hernández (Y)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.

Gisselle Fernández (G)

Institute of Basic and Preclinical Sciences "Victoria de Girón" (ICBP), Medical University of Havana (UCMH), La Habana, Cuba.

Carlos Luis Pérez (CL)

Institute of Basic and Preclinical Sciences "Victoria de Girón" (ICBP), Medical University of Havana (UCMH), La Habana, Cuba.

Juan Carlos Rodriguez (JC)

Department of Pathology, National Institute of Oncology and Radiobiology, La Habana, Cuba.

Miguel David Fernández (MD)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.

Ivones Hernández-Balmaseda (I)

Department of Pharmacology, Institute of Marine Sciences (ICIMAR), La Habana, Cuba.

Julio Raul Fernández (JR)

Department of Genomic, Center for Genetic Engineering and Biotechnology, La Habana, Cuba.

Fernando Mesta (F)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Mexico City, Mexico.

Miriam Teresa Paz (MT)

Pharmacology Department, Institute of Biological Sciences (ICB), Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH